Clinical Trials Browser

Phase 2 × Hydroxychloroquine × Other hematologic neoplasm × Clear all

NCT04392128 2020-09-04

HYACINTHE

Phase 2 Withdrawn

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT01227135 2011-11-30

Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase